Modernising the USP HPLC method for acetaminophen and caffeine tablets

Published: 30-Jan-2025

New approach to USP <621> guidelines delivers faster analysis, reduced solvent use, and improved performance with no revalidation required.

The Agilent updated HPLC method for acetaminophen and caffeine tablets, aligned with revised USP <621> guidelines, employs smaller particle size columns, including Agilent ZORBAX Eclipse Plus and InfinityLab Poroshell 120 EC-C18. This modernisation results in faster analysis, reduced solvent consumption, and eliminates the need for revalidation. The method meets all system suitability requirements, enhancing efficiency and sustainability in pharmaceutical testing.

Read the full application note here.

You may also like